Key result
Quantitative autonomic testing diagnoses autonomic neuropathy and evaluates therapy efficacy in patients with diabetes.
Why the study?
Autonomic neuropathy is a disabling and life-threatening complication of diabetes mellitus requiring timely diagnosis and early therapy to improve survival and quality of life.
Quantitative autonomic testing is a valuable tool for diagnosing cardiovascular autonomic neuropathy and monitoring treatment efficacy in patients with diabetes.
Answers are grounded in this paper and cite their sources.
Quantitative autonomic testing aids AN diagnosis and monitoring; leaves open routine adoption pending higher-level evidence.
Autonomic neuropathy (AN) is a disabling and life-threatening complication of diabetes mellitus and a number of other diseases. The timely diagnosis of this condition and early initiation of its therapy make it possible to prolong life and to improve its quality. The quantitative autonomic testing procedure permits one not only to diagnose AN and to detect the degree of autonomic nerve fiber lesion, but also to trace a trend in autonomic disorders during treatment, i.e. to evaluate the efficiency of therapy for cardiovascular AN.
No takes yet. Share an insight, caveat, or question.
Barinov et al. (2011) conducted a review in Autonomic neuropathy in diabetes mellitus. Quantitative autonomic testing allows for the diagnosis of autonomic neuropathy, detection of nerve fiber lesions, and evaluation of therapy efficiency in patients with diabetes mellitus.
Synapse has enriched 10 related papers. Consider them for comparative context: